Lyra Therapeutics Inc
LYRA
$0.19+0.00%
End of day · as of Oct 16, 2026, 8:00 PM ET
Mkt cap
$14.39M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$398,000
EPS (9mo ended 2025-09-30)
$-0.29
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-7266.08%
Beta
0.01
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported LYRA revenue for 2025-12-31 was $398.0K. Net income was -$28.9M. Revenue was down 74.1% from 2024-12-31 to 2025-12-31. LYRA currently screens at market cap $14.4M.
Use this LYRA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LYRA income, balance, and cash tables.
Lyra Therapeutics Inc (LYRA) is a biotechnology company in the Healthcare sector.
Latest cached Lyra Therapeutics Inc (LYRA) revenue for Dec 31, 2025 was $398.0K. Net income was -$28.9M. Statements: https://lician.com/financials/lyra
Lyra Therapeutics Inc (LYRA) market capitalization is $14.4M on the latest cached snapshot.
Lyra Therapeutics Inc (LYRA) cached previous close $0.19; day range $0.19 – $0.52; volume 5,469. Session quote: https://lician.com/quote/lyra